Susan G. Komen awards $21.7 million to 48 new analysis initiatives geared toward bettering breast most cancers affected person outcomes

Susan G. Komen®, the world’s main breast most cancers group, is awarding $21.7 million to fund 48 new analysis initiatives at 26 distinguished tutorial medical establishments within the U.S. which might be targeted on bettering affected person outcomes – notably for individuals with probably the most aggressive breast cancers, or who’ve skilled a recurrence or metastasis. With this funding, Komen is now supporting greater than 152 energetic analysis initiatives representing greater than $115 million in funding.

The funding we’re asserting immediately in a broad portfolio of cutting-edge analysis will assist advance breast most cancers care and enhance outcomes for all individuals diagnosed with breast cancer, together with underserved populations and people with few remedy choices. With this funding, we’re supporting among the high breast most cancers researchers who share our mission and giving everybody impacted by breast most cancers hope, as we transfer nearer to the cures for breast cancers.”

Victoria Wolodzko Sensible, SVP of Mission at Susan G. Komen

Of the full $21.7 million awarded immediately:

  • 79 p.c helps analysis targeted on probably the most aggressive breast cancers, metastasis and recurrence;
  • 33 p.c helps scientific trials;
  • 20 p.c helps analysis targeted on eliminating breast most cancers disparities;

“We nonetheless have a lot to study aggressive breast cancers and breast cancers that recur and metastasize. This important analysis funding from Susan G. Komen will assist us unravel the biology of breast cancers to higher perceive the way to stop breast most cancers recurrence and metastasis, and develop extra remedy choices, together with new remedies for individuals dwelling with metastatic breast cancer,” stated Jennifer Pietenpol, Ph.D., Susan G. Komen Chief Scientific Advisor.

Pietenpol additionally serves because the Benjamin F. Byrd, Jr. Professor of Oncology, Chief Scientific and Technique Officer and Govt Vice President for Analysis at Vanderbilt College Medical Heart.

Komen analysis grants are being awarded to the next research investigators at 26 preeminent U.S. establishments:

Julie Palmer, Sc.D., M.P.H., Boston College
Jennifer Ligibel, M.D., FASCO, Dana-Farber Most cancers Institute
Nancy Lin, M.D., Dana-Farber Most cancers Institute
Kornelia Polyak, M.D., Ph.D., Dana-Farber Most cancers Institute
Sara Tolaney, M.D., M.P.H., Dana-Farber Most cancers Institute
Nikhil Wagle, M.D., Dana-Farber Most cancers Institute
Sunil Badve, M.D., FRCPath, Emory College College of Medication
Maria Sosa, Ph.D., Icahn College of Medication at Mount Sinai
Tarah Ballinger, M.D., Indiana College
Pedram Razavi, M.D., Ph.D., Memorial Sloan Kettering Most cancers Heart
Jorge Reis-Filho, M.D., Ph.D., FRCPath, Memorial Sloan Kettering Most cancers Heart
Sohrab Shah, Ph.D., Memorial Sloan Kettering Most cancers Heart
Lisa Coussens, Ph.D., Oregon Well being & Science College
Yibin Kang, Ph.D., Princeton College
Hai Wang, Ph.D., Roswell Park Most cancers Institute
Christina Curtis, Ph.D., M.S., Stanford College College of Medication
Melinda Telli, M.D., Stanford College College of Medication
Allison Kurian, M.D., M.Sc., Stanford College College of Medication
Haruka Itakura, M.D., Ph.D., Stanford College College of Medication
Daniel Hollern, Ph.D., The Salk Institute for Organic Research
Reshma Jagsi, M.D., D.Phil., College of Michigan
Melissa Troester, Ph.D., College of North Carolina at Chapel Hill
Angela DeMichele, M.D., M.S.C.E., College of Pennsylvania
Adrian Lee, Ph.D., College of Pittsburgh
Steffi Oesterreich, Ph.D., College of Pittsburgh
Alana Welm, Ph.D., College of Utah Huntsman Most cancers Institute
Amelie Ramirez, Dr.P.H., M.P.H., UT Well being San Antonio
Mariana Chavez MacGregor, M.D., M.Sc., FASCO, UT M.D. Anderson Most cancers Heart
Sharon Giordano, M.D., M.P.H., FASCO, UT M.D. Anderson Most cancers Heart
Srinivas Malladi, Ph.D., UT Southwestern Medical Heart
Tuya Pal, M.D., Vanderbilt College Medical Heart
Ben Ho Park, M.D., Ph.D., Vanderbilt College Medical Heart
Jennifer Pietenpol, Ph.D., Vanderbilt College Medical Heart
Sonya Reid, M.D., Ph.D., Vanderbilt College Medical Heart
Cynthia Ma, M.D., Ph.D., Washington College
Rulla Tamini, Sc.D., Weill Cornell Faculty of Cornell College
Mariya Rozenblit, M.D., Yale College
Lajos Pusztai, M.D., D.Phil., Yale College

Komen has invested greater than $1 billion in breast most cancers analysis within the 40 years since its founding, greater than another non-profit, and second solely to the U.S. authorities.

Source

Share

Leave a Reply